Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$4.81 - $6.99 $596,738 - $867,193
-124,062 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.97 - $7.93 $740,650 - $983,811
124,062 New
124,062 $845,000
Q4 2020

Feb 16, 2021

SELL
$5.25 - $8.56 $135,019 - $220,146
-25,718 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$5.78 - $7.47 $148,650 - $192,113
25,718 New
25,718 $161,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $322M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.